Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA warns Teva over California plant

April 30, 2010
Manufacturing and Production Teva, manufacturing compliance

Teva has become the latest drugmaker to be rebuked by the FDA for not responding effectively enough to compliance problems …

News

Plavix boosts BMS first quarter figures

April 30, 2010
Sales and Marketing BMS, Plavix

Plavix has boosted Bristol-Myers Squibb’s performance in the first quarter of the year, with sales of the anti-clotting blockbuster up …

News
Frazier

Merck separates president role, appoints Kenneth Frazier

April 30, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing

Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …

Appointment

Victoza claims head-to-head victory over Januvia

April 29, 2010
Research and Development, Sales and Marketing Novo, Novo Nordisk, Victoza

Novo Nordisk says its diabetes treatment showed “significant” benefits over Merck’s rival Januvia in a head-to-head trial. Results published in …

News

Investors get green light to continue Merck lawsuit

April 29, 2010
Merck, Vioxx

Investors suing Merck over ‘omissions and misstatements’ relating to its arthritis pain drug Vioxx will be allowed to continue with …

News

CME Spotlight: De-coding the letter of the law

April 29, 2010
Medical Communications CME, CME Spotlight

Legal systems can raise interesting philosophical points sometimes.At the time of writing, the UK is in the throws of a …

Feature

Doctors.net.uk reports record year for online interaction with doctors

April 29, 2010
Medical Communications CME, doctors.net, social networking

Online doctors’ community Doctors.net.uk says it saw record levels of doctor engagement in 2009, with 25 million unique web sessions during …

News

US pharma execs join Algeta board

April 29, 2010
Research and Development Algeta, appointment, research and development

Oslo-based oncology company Algeta has added Judith Hemberger and Kapil Dhingra to its board of directors. Judith Hemberger has more …

Appointment

RNA Interference using nanoparticles hits target in human patients

April 29, 2010
Research and Development SiRNA, nanoparticles, rnai

US researchers have shown that a targeted nanoparticle can penetrate cancer cells in order to deliver small interfering RNAs (siRNAs), …

News

Asia and emerging markets boost GSK results

April 28, 2010
Sales and Marketing GSK

Asia and emerging markets boost GlaxoSmithKline results GlaxoSmithKline has seen a jump in pharma sales due to major growth in …

News

Merck bounces back

April 28, 2010
Sales and Marketing Merck KGaA

Merck KgaA tripled its profit year-on-year in the first quarter of 2010, largely on the back of a better than …

News

Obituary – Tony Forbes-Leith

April 28, 2010
Business Services appointment, business services, rsa

RSA director Tony Forbes-Leith passed away last month after a long and serious illness. He officially joined the company in …

Appointment

AstraZeneca settles Seroquel marketing charges

April 28, 2010
Sales and Marketing Seroquel

AstraZeneca has agreed to pay $520 million to settle US federal investigations into the marketing of its antipsychotic blockbuster Seroquel. …

News
Robert_Bradway

Amgen promotes Robert Bradway to president

April 28, 2010
Manufacturing and Production, Sales and Marketing Amgen, appointment, manufacturing and production, sales and marketing

Robert Bradway has been appointed president and chief operating officer at US biotech Amgen. Bradway, currently executive VP and chief …

Appointment

GE Healthcare and Nycomed in Russian joint venture

April 27, 2010
Sales and Marketing GE Healthcare, Nycomed

GE Healthcare and Nycomed have formed a joint venture to market and distribute GE Healthcare’s medical diagnostic contrast agents in …

News
Crestor

Crestor gains prevention licence in Europe

April 27, 2010
Sales and Marketing AstraZeneca, Crestor, statin

AstraZeneca’s statin treatment Crestor has been approved in the European Union for the prevention of major cardiovascular events in patients …

News

Turn your people into your competitive advantage

April 27, 2010
Business Services careers voice, rsa, talking careers

Nick Stephens, chief executive of RSA, outlines and analyses the major HR and people management issues global life sciences executives’ …

Feature

Dr Pia Garguilo and Richard Watts join Qiagen

April 27, 2010
Sales and Marketing Qiagen, appointment, sales and marketing

Netherlands-based diagnostics company Qiagen has made two appointments to its new pharma business development team. Dr Pia Gargiulo joins as …

Appointment

Charles River to buy WuXi for $1.6bn

April 27, 2010
Research and Development Charles River, Charles River Laboratories, WuXi, contract research

Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …

News

Synovate appoints Manfred Eberlein

April 26, 2010
Sales and Marketing appointment, sales and marketing, synovate

Pharma research company Synovate Healthcare has appointed Manfred Eberlein to head up its operations in Western Europe. In his new …

Appointment
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026